Related Experiment Video

Updated: Dec 31, 2025

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.9K

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer

Hai-Hong Zhou1, Xu Chen1, Lu-Ya Cai1

  • 1Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Frontiers in Oncology
|January 11, 2020
PubMed

Insights

Erastin reverses drug resistance in ovarian cancer by inhibiting ABCB1 efflux, enhancing docetaxel efficacy. This combination therapy shows promise for chemo-resistant ovarian cancer patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Overexpression of ABCB1 (P-glycoprotein) is a key mechanism of multidrug resistance (MDR) in cancer.
  • ABCB1 upregulation contributes to docetaxel resistance and poor outcomes in ovarian cancer.
  • Erastin, a ferroptosis inducer targeting SLC7A11, presents a potential therapeutic avenue.

Purpose of the Study:

  • To investigate the synergistic effects of erastin and docetaxel in ovarian cancer.
  • To elucidate the mechanism by which erastin impacts ABCB1-mediated drug resistance.

Main Methods:

  • Cell viability assays were performed on ovarian cancer cells with ABCB1 overexpression.
  • Apoptosis and cell cycle analysis were conducted.
  • Intracellular substrate levels and ABCB1 expression were measured to understand the mechanism.

Main Results:

  • Co-delivery of erastin and docetaxel significantly reduced ovarian cancer cell viability.
  • The combination induced apoptosis and G2/M cell cycle arrest.
  • Erastin enhanced intracellular docetaxel levels by inhibiting ABCB1 efflux without altering ABCB1 expression.

Conclusions:

  • Erastin effectively reverses ABCB1-mediated docetaxel resistance in ovarian cancer.
  • The combination of erastin and docetaxel offers a potential therapeutic strategy for chemo-resistant ovarian cancers.
Keywords:
ABCB1docetaxelerastinferroptosisovarian cancer

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.7K
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

13.8K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K